Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Nebivolol on Ocular Perfusion in Patients with Arterial Hypertension and Glaucoma
2004-004862-33Phase 4Terminated
- Sponsor
- Berlin-Chemie AG
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nebivolol in hypertension (HTN) and Glaucoma (2 arms), sponsored by Berlin-Chemie AG. Primary endpoint: Primary efficacy variable. Started Feb 2007; status: terminated.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)Glaucoma
Beyond the preview
Go deeper on 2004-004862-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004862-33.